查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494621

个人化医疗市场：按产品、应用和最终用户划分 - 全球预测 2024-2030

Personalized Medicine Market by Product (Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), Application (Antiviral, Cardiology, Immunology), End Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年个人化医疗市场规模为5,421亿美元，预计2024年将达5,755亿美元，2030年将达8,520.2亿美元，复合年增长率为6.67%。

个人化医疗是客製化的医疗保健，根据个别患者的情况（包括遗传、分子、环境和生活方式因素）量身订做治疗方案。这种适应性医学充分利用基因组学、即时诊断等关键技术，涵盖诊断、治疗、个体化医疗、个人化营养指导等广泛应用。该市场的成长归因于人工智慧等技术进步以及由于全球个人慢性病盛行率不断上升而需要个人化健康干预措施。然而，研究和基础设施开发的高额初始投资，以及与使用个人化医疗相关的隐私问题，可能会阻碍市场成长。人工智慧、行动医疗技术和再生医学提供了大量可以改变治疗模式的创新机会。此外，全球健康资料整合的增加以及公众和专业人士参与的增加可能会进一步促进个人化医疗解决方案的广泛采用。

主要市场统计
基准年[2023] 5421亿美元
预测年份 [2024] 5755亿美元
预测年份 [2030] 8520.2亿美元
复合年增长率（%） 6.67%

区域洞察

在北美，政府和私营部门的大量投资正在推动市场发展，在肿瘤学和心臟病学等领域明显倾向于个人化医疗。该地区强调将个人化医疗纳入公共卫生保健系统。在南美洲，特别是在巴西、阿根廷和智利，基因检测的普及使得预防医学和量身定制的治疗策略成为可能。当地研究机构和全球研究公司之间合作的增加也补充了这种成长。在欧盟委员会的支持以及与个人化医疗相关的伦理和法律的大力关注下，欧盟 (EU) 对个人化医疗研究表现出越来越浓厚的兴趣。中东和非洲在这一领域正在兴起，以色列和沙乌地阿拉伯在发展个体化医疗方面取得了长足进步，各国政府专注于医疗改革和教育。南非正在利用其独特的遗传多样性为世界其他地区开拓基因组医学计划。亚太地区在透过个人化医疗策略利用技术力来解决遗传疾病和癌症负担沉重的老龄化人口方面正在取得快速进展。该地区的消费者越来越愿意参与基因检测和个人化医疗保健计划。政府策略性倡议着重于基因组学和个人化医疗解决方案，以解决遗传疾病和各种癌症的高盛行率。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在个人化医疗市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对个人化医疗市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在个人化医疗市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。这项关键评估涉及对组织的资源、能力和整体绩效的彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加强生物技术研究力度并提高对遗传学的了解
      • 快速采用针对复杂疾病的个人化医疗策略
      • 政府支持活动，以提高对个人化医疗的认识和获取
    • 抑制因素
      • 实施个人化医疗的复杂性和缺乏熟练人员
    • 机会
      • 持续的研发活动以改善个人化医疗
      • 采用虚拟和数位策略进行个人化医疗的可能性
    • 任务
      • 可访问性限制和准确性问题
  • 市场区隔分析
    • 副产品：个人化营养和健康的引入正在提高人们对身体健康和心理健康的认识。
    • 依应用分类：由于需要精准治疗，个人化医疗在神经学的应用越来越多
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章个人化医疗市场：副产品

  • 个人化医疗护理
  • 个性化医疗诊断
  • 个人化医疗
  • 个人化营养与健康

第七章个人化医疗市场：依应用分类

  • 抗病毒药
  • 心臟病学
  • 免疫学
  • 神经病学
  • 肿瘤学
  • 精神病学

第八章个人化医疗市场：依最终用户分类

  • 学术研究机构与实验室
  • 生物/健康资讯学公司
  • 受託研究机构
  • 诊断公司和检测机构
  • 医院和临床护理

第九章美洲个人化医疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太个人化医疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲个人化医疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • 阿斯特捷利康收购 Fusion Pharmaceuticals 开发个人化癌症药物
    • CurifyLabs 从 Mehta Heino Industries 收购关键 3D 列印 IP，以推进个人化医疗解决方案
    • 策略性收购增强诺华精准医疗能力
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4D00F1312F65

[183 Pages Report] The Personalized Medicine Market size was estimated at USD 542.10 billion in 2023 and expected to reach USD 575.50 billion in 2024, at a CAGR 6.67% to reach USD 852.02 billion by 2030.

Personalized medicine is customized healthcare that aligns medical treatments with individual patient profiles, which include genetic, molecular, environmental, and lifestyle factors. This adaptive practice spans diverse applications, including diagnostics, therapeutics, tailored medical care, and customized nutritional guidance, using key technologies such as genomics and real-time diagnostics. Growth in this market is due to advancements in technology, such as AI, and the necessity of personalized health interventions due to the increasing prevalence of chronic disease rates among individuals around the globe. However, high initial cost investment for research and infrastructure and privacy concerns associated with the use of personalized medicine use can hinder market growth. Opportunities for innovation abound in AI, mobile health technologies, and regenerative medicine, which can shift therapeutic paradigms. Additionally, the push towards global health data integration and heightened public and professional engagement can further encourage the broad adoption of personalized health solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 542.10 billion
Estimated Year [2024] USD 575.50 billion
Forecast Year [2030] USD 852.02 billion
CAGR (%) 6.67%

Regional Insights

In North America, the market is propelled by substantial investments from both government and private sectors, with a clear inclination towards personalized treatments observed in fields such as oncology and cardiology. The region emphasizes the integration of personalized medicine into public healthcare systems. In South America, mainly Brazil, Argentina, and Chile, the surge in genetic testing enabled preventative care and tailored treatment strategies. This growth is complemented by increasing collaborations between local research entities and global research firms. European Union showed a growing interest in personalized medical research, with backing from the European Commission and an acute focus on the ethical and legal dimensions associated with personalized medicine. The Middle East and Africa are emerging in this arena, with Israel and Saudi Arabia making significant strides in the development of customized medicine by increasing governmental focus on healthcare reform and education. South Africa is leveraging its unique genetic diversity to pioneer genomic medicine projects for the rest of the world with active investment for global organizations in healthcare and research. The Asia Pacific region showcases rapid progress with technological prowess to cater to its aging population through personalized healthcare strategies for its high burden of genetic diseases and cancer. The region is showing increased consumer readiness to participate in genetic testing and personalized healthcare programs. The government's strategic initiatives emphatically support genomics and personalized treatment solutions in response to the high prevalence of genetic diseases and various cancers within the population.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Personalized Medicine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rise in biotechnology research initiatives and improved understanding of genetics
      • Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • Supportive government initiatives to raise awareness for and access to personalized medicine
    • Market Restraints
      • Complexities in the implementation of personalized medicine and lack of skilled personnel
    • Market Opportunities
      • Ongoing R&D activities for improvements in personalized medicines
      • Potential for the adoption of virtual and digital strategies for personalized medicine
    • Market Challenges
      • Limited accessibility and issues related to accuracy
  • Market Segmentation Analysis
    • Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Personalized Medicine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Personalized Medicine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine

AstraZeneca acquired Fusion Pharmaceuticals, a biopharmaceutical company specializing in next-generation radioconjugates, in a deal potentially worth up to USD 2400 million. This acquisition represents a pivotal development in the cancer treatment landscape, with Fusion enhancing AstraZeneca's capacity to deliver innovative, patient-specific therapies. [Published On: 2024-03-19]

CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions

CurifyLabs, a health technology company, acquired significant intellectual property from Mehta Heino Industries Oy. This acquisition aims to enhance CurifyLabs' capabilities in producing personalized medicines for hospitals and compounding pharmacies, focusing particularly on pediatric populations. This acquisition is pivotal for pioneering new frontiers in personalized medicine and fortifying the company's expertise in 3D printing and advanced robotics. [Published On: 2024-01-17]

Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities

Novartis successfully acquired Chinook Therapeutics, a company specializing in precision medicines. This move aligns with Novartis' strategic objective to broaden its portfolio in the precision medicine sector, particularly in developing advanced treatments for kidney diseases. The integration of Chinook's expertise is anticipated to strengthen Novartis' position in the market, facilitating better-targeted and more effective healthcare solutions. [Published On: 2023-08-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Personalized Medicine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Personalized Medical Care
      • Health Information Technology
      • Telemedicine
    • Personalized Medicine Diagnostics
      • Direct-to-consumer (DTC) Diagnostics
      • Esoteric Lab Services
      • Esoteric Lab Tests
      • Genetic Testing
    • Personalized Medicine Therapeutics
      • Genomic Medicine
      • Medical Devices
      • Pharmaceutical
    • Personalized Nutrition & Wellness
      • Complementary & Alternative Medicine
      • Retail Nutrition
  • Application
    • Antiviral
    • Cardiology
    • Immunology
    • Neurology
    • Oncology
    • Psychiatry
  • End Users
    • Academic Research Institutes & Research Laboratories
    • Bio & Health Informatics Companies
    • Contract Research Organizations
    • Diagnostic Companies & Testing Facilities
    • Hospitals & Clinical Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
      • 5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • 5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
      • 5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited accessibility and issues related to accuracy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • 5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Personalized Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Personalized Medical Care
  • 6.3. Personalized Medicine Diagnostics
  • 6.4. Personalized Medicine Therapeutics
  • 6.5. Personalized Nutrition & Wellness

7. Personalized Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Antiviral
  • 7.3. Cardiology
  • 7.4. Immunology
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Psychiatry

8. Personalized Medicine Market, by End Users

  • 8.1. Introduction
  • 8.2. Academic Research Institutes & Research Laboratories
  • 8.3. Bio & Health Informatics Companies
  • 8.4. Contract Research Organizations
  • 8.5. Diagnostic Companies & Testing Facilities
  • 8.6. Hospitals & Clinical Care

9. Americas Personalized Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Personalized Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Personalized Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
    • 12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
    • 12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN PERSONALIZED M